SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
Europe - FRA:SRT3 - DE0007165631
223.15 EUR
-0.65 (-0.29%)
SRT3 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. SRT3 has a bad profitability rating. Also its financial health evaluation is rather negative. SRT3 is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SRT3 had positive earnings in the past year.
SRT3 had a positive operating cash flow in the past year.
In the past 5 years SRT3 has always been profitable.
SRT3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.39%, SRT3 is doing worse than 83.33% of the companies in the same industry.
The Return On Equity of SRT3 (5.01%) is worse than 77.78% of its industry peers.
SRT3 has a worse Return On Invested Capital (4.71%) than 77.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SRT3 is significantly below the industry average of 13.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
The Profit Margin of SRT3 (3.80%) is worse than 83.33% of its industry peers.
In the last couple of years the Profit Margin of SRT3 has declined.
SRT3 has a worse Operating Margin (14.06%) than 72.22% of its industry peers.
In the last couple of years the Operating Margin of SRT3 has declined.
With a decent Gross Margin value of 46.48%, SRT3 is doing good in the industry, outperforming 77.78% of the companies in the same industry.
SRT3's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
SRT3 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SRT3 has more shares outstanding
The number of shares outstanding for SRT3 has been increased compared to 5 years ago.
Compared to 1 year ago, SRT3 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.31 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.31, SRT3 is doing worse than 61.11% of the companies in the same industry.
The Debt to FCF ratio of SRT3 is 8.92, which is on the high side as it means it would take SRT3, 8.92 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.92, SRT3 is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.28 is on the high side and indicates that SRT3 has dependencies on debt financing.
SRT3 has a worse Debt to Equity ratio (1.28) than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.31 |
ROIC/WACC0.59
WACC7.96%
2.3 Liquidity
SRT3 has a Current Ratio of 0.95. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SRT3 (0.95) is worse than 83.33% of its industry peers.
SRT3 has a Quick Ratio of 0.95. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.49, SRT3 is doing worse than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 59.34% over the past year.
The earnings per share for SRT3 have been decreasing by -11.87% on average. This is quite bad
Looking at the last year, SRT3 shows a small growth in Revenue. The Revenue has grown by 5.82% in the last year.
Measured over the past years, SRT3 shows a quite strong growth in Revenue. The Revenue has been growing by 13.10% on average per year.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
The Earnings Per Share is expected to grow by 19.28% on average over the next years. This is quite good.
SRT3 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.99% yearly.
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
EPS Next 5Y19.28%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.23%
Revenue Next 5Y8.99%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
SRT3 is valuated quite expensively with a Price/Earnings ratio of 48.94.
Based on the Price/Earnings ratio, SRT3 is valued more expensive than 88.89% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.47. SRT3 is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 36.87, which means the current valuation is very expensive for SRT3.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRT3 indicates a rather expensive valuation: SRT3 more expensive than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.42, SRT3 is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.94 | ||
| Fwd PE | 36.87 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as SRT3.
SRT3's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.91 | ||
| EV/EBITDA | 22.27 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as SRT3's earnings are expected to grow with 21.20% in the coming years.
PEG (NY)2.16
PEG (5Y)N/A
EPS Next 2Y21.53%
EPS Next 3Y21.2%
5. Dividend
5.1 Amount
SRT3 has a yearly dividend return of 0.40%, which is pretty low.
SRT3's Dividend Yield is comparable with the industry average which is at 0.74.
Compared to an average S&P500 Dividend Yield of 2.44, SRT3's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
37.92% of the earnings are spent on dividend by SRT3. This is a low number and sustainable payout ratio.
The dividend of SRT3 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP37.92%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
FRA:SRT3 (11/20/2025, 12:44:08 PM)
223.15
-0.65 (-0.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.71B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target342.38 (53.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.71%
PT rev (3m)4.38%
EPS NQ rev (1m)3.45%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)-0.47%
EPS NY rev (3m)-0.17%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)2.71%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.94 | ||
| Fwd PE | 36.87 | ||
| P/S | 4.75 | ||
| P/FCF | 34.91 | ||
| P/OCF | 19.11 | ||
| P/B | 6.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.27 |
EPS(TTM)4.56
EY2.04%
EPS(NY)6.05
Fwd EY2.71%
FCF(TTM)6.39
FCFY2.86%
OCF(TTM)11.68
OCFY5.23%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)2.16
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.31 |
F-Score7
WACC7.96%
ROIC/WACC0.59
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
EPS Next 5Y19.28%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.23%
Revenue Next 5Y8.99%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year99.69%
EBIT Next 3Y38.21%
EBIT Next 5Y26.8%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG-VORZUG / SRT3.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
What is the valuation status for SRT3 stock?
ChartMill assigns a valuation rating of 2 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG-VORZUG?
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for SRT3 stock?
The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 48.94 and the Price/Book (PB) ratio is 6.26.
What is the expected EPS growth for SARTORIUS AG-VORZUG (SRT3.DE) stock?
The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 22.69% in the next year.